Clinical Trials Logo

Virtual Reality clinical trials

View clinical trials related to Virtual Reality.

Filter by:
  • Suspended  
  • Page 1

NCT ID: NCT04268914 Suspended - Pain Clinical Trials

Virtual Reality to Reduce Pre-Operative Anxiety

Start date: December 4, 2015
Phase: N/A
Study type: Interventional

This study aims to test the effectiveness of virtual reality (VR) as a non-pharmaceutical intervention to reduce pain and anxiety in children undergoing various procedures in the Ambulatory Surgery Center (ASC) at CHLA, as measured by self- and proxy-report.

NCT ID: NCT03801616 Suspended - Pain, Postoperative Clinical Trials

Virtual Reality After Breast Reconstruction Surgery

VR4BR
Start date: January 1, 2019
Phase: N/A
Study type: Interventional

This is a pilot study of virtual reality (VR) non-opioid management for women undergoing mastectomy and implant-based reconstruction. Study participants will receive specialized VR interventions, administered via VR headsets, to manage pain.

NCT ID: NCT03715400 Suspended - Depression Clinical Trials

Mobile Virtual Positive Experiences for Anhedonia

MVR
Start date: September 1, 2018
Phase: N/A
Study type: Interventional

Anhedonia is a symptom dimension that characterizes many individuals suffering from depression, as well as some types of anxiety, psychosis, and substance use. For the most part, treatments are effective in decreasing negative affect but ineffective in improving anhedonia, with some antidepressant medications even worsening symptoms of anhedonia. Yet anhedonia is a significant marker of poor prognosis as well as suicidal ideation and actual suicide. The development of effective treatments for anhedonia is thus of paramount importance. Advances in neuroscience indicate specific targets that may underlie anhedonia that can be shifted through behavioral training. The investigators have developed such a program and found it to be effective in raising positive affect, especially for depressed or anxious individuals with anhedonia at baseline. To date, this program has been implemented by highly trained clinicians, which have supervised its implementation on a large scale. Moreover, the behavior program is dependent on readily available rewarding experiences, which anhedonia obviously challenges. Furthermore, mechanistic evaluation is impeded by intra¬- and inter-¬individual variability in exposure to rewarding stimuli. Virtual Reality (VR) offsets these barriers by repeated controlled immersion in experiences designed to enhance approach motivation, initial responsiveness to reward attainment, and reward learning. In this current study, the investigators aim to measure clinical outcomes using Virtual Reality-Reward Training (VR-RT).